Search Results - "MINUTELLO, Ada"

Serum-free purified Vero rabies vaccine is safe and immunogenic in children: Results of a randomized phase II pre-exposure prophylaxis regimen study by Quiambao, Beatriz, Montalban, Cecilia, Minutello, Ada-Maria, Guinet-Morlot, Françoise, Moureau, Annick, Petit, Celine, Pichon, Sylvie

“…BackgroundA serum-free, highly purified Vero rabies vaccine (PVRV-NG) has been developed with no animal or human components and low residual DNA content. A…”
Get full text

Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® Rabies) administered in a simulated rabies post-exposure regimen in healthy adults by Pichon, Sylvie, Moureau, Annick, Petit, Celine, Kirstein, Judith L., Sheldon, Eric, Guinet-Morlot, Francoise, Minutello, Ada-Maria

“…A new generation, serum-free, antibiotic-free, purified Vero rabies vaccine (PVRV-NG; Sanofi) has been developed based on the same Pitman-Moore viral strain…”
Get full text

Safety and immunogenicity of a serum-free purified Vero rabies vaccine in healthy adults: A randomised phase II pre-exposure prophylaxis study by Pichon, Sylvie, Moureau, Annick, Petit, Celine, Chu, L., Essink, B., Muse, D., Saleh, J., Guinet-Morlot, Françoise, Minutello, Ada-Maria

“…•A three-dose PrEP regimen with PVRV-NG was immunogenically non-inferior to HDCV.•98.3% of PVRV-NG recipients had titres ≥ 0.5 IU/mL.•Primary PrEP with PVRV-NG…”
Get full text

Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults by Pichon, Sylvie, Guinet-Morlot, Francoise, Saleh, Jamshid, Essink, Brandon, Pineda-Peña, Andrea-Clemencia, Moureau, Annick, Petit, Celine, Minutello, Ada-Maria

“…A serum-free, highly purified rabies vaccine produced in Vero cells is under development. The initial formulation, PVRV-NG, was evaluated in five Phase II…”
Get full text

Phase I Evaluation of Intranasal Trivalent Inactivated Influenza Vaccine with Nontoxigenic Escherichia coli Enterotoxin and Novel Biovector as Mucosal Adjuvants, Using Adult Volunteers by STEPHENSON, Lain, ZAMBON, Maria C, MILLS, Kingston H. G, NICHOLSON, Karl G, RUDIN, Anna, COLEGATE, Anthony, PODDA, Audino, BUGARINI, Roberto, DEL GIUDICE, Giusseppe, MINUTELLO, Ada, BONNINGTON, Susan, HOLMGREN, Jan

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Serum-free purified Vero rabies vaccine is safe and immunogenic in children: Results of a randomized phaseII pre-exposure prophylaxis regimen study by Quiambao, Beatriz, Montalban, Cecilia, Minutello, Ada-Maria, Guinet-Morlot, Françoise, Moureau, Annick, Petit, Celine, Pichon, Sylvie

“…•Phase II trial evaluating efficacy and safety of candidate rabies vaccine. PVRV-NG.•PVRV-NG was compared with Imovax® Rabies (HDCV) in healthy children and…”
Get full text

Immunogenicity and Safety of a Purified Vero Rabies Vaccine—Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial by Pineda-Peña, Andrea-Clemencia, Jiang, Qian, Petit, Celine, Korejwo-Peyramond, Joanna, Donazzolo, Yves, Latreille, Mathilde, Homery, Marie-Claude, Babin, Valerie, Benamor, Sonia, Pichon, Sylvie, Guinet-Morlot, Françoise, Minutello, Ada-Maria

“…Abstract Background A next-generation Vero cell rabies vaccine (PVRV-NG2) was developed using the same Pitman–Moore strain as in the licensed purified Vero…”
Get full text

Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trial by Modjarrad, Kayvon, Scott, Paul T, McCauley, Melanie, Ober-Shepherd, Brittany, Sondergaard, Erica, Amare, Mihret F, Parikh, Ajay P, Omar, Badryah, Minutello, Ada-Marie, Adhikarla, Haritha, Wu, Yukun, P, Andrey Rojas, Delore, Valentine, Mantel, Nathalie, Morrison, Meshell N, Kourbanova, Kamila S, Martinez, Melissa E, Guzman, Ivelese, Greenleaf, Melissa E, Darden, Janice M, Koren, Michael A, Hamer, Melinda J, Lee, Christine E, Hutter, Jack N, Peel, Sheila A, Robb, Merlin L, Vangelisti, Manuel, Feroldi, Emmanuel

“…Recent outbreaks between 2015–17 and production delays have led to a yellow fever vaccine shortage. Therefore, there is an urgent need for new yellow fever…”
Get full text

An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine by Giudice, Giuseppe Del, Hilbert, Anne Katrin, Bugarini, Roberto, Minutello, Ada, Popova, Olga, Toneatto, Daniela, Schoendorf, Ines, Borkowski, Astrid, Rappuoli, Rino, Podda, Audino

“…To test whether inactivated influenza vaccines distributed during the 2003–2004 influenza season in the northern hemisphere were able to confer protection…”
Get full text

Thiomersal removal: effects on the safety and immunogenicity of the chiron influenza vaccines AGRIPPAL® and FLUAD by Toneatto, Daniela, Bugarini, Roberto, Corbellini, Barbara, Penlington, Michael, Vaccina, Domenico, Minutello, Ada

“…Thiomersal is an organic mercurial compound that has been used for over 60 years as an antimicrobial agent to prevent bacterial and fungal contamination. Due…”
Get full text